Steven Cohen's VCYT Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 426,229 shares of Veracyte, Inc. (VCYT) worth $17.94 M, representing 0.02% of the portfolio. First purchased in 2019-Q1, this medium-term investment has been held for 18 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in VCYT, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2023, adding 1.12 M shares. Largest reduction occurred in Q3 2023, reducing 676,079 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Veracyte (VCYT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Veracyte (VCYT) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +426,229 | New Buy | 426,229 | $42.10 |
| Q2 2025 | -25,159 | Sold Out | 0 | $0.00 |
| Q1 2025 | -498,003 | Reduce 95.19% | 25,159 | $29.65 |
| Q4 2024 | +523,162 | New Buy | 523,162 | $39.60 |
| Q3 2024 | -566,634 | Sold Out | 0 | $0.00 |
| Q2 2024 | +566,634 | New Buy | 566,634 | $21.67 |
| Q1 2024 | -44,700 | Sold Out | 0 | $0.00 |
| Q4 2023 | -397,287 | Reduce 89.89% | 44,700 | $27.51 |
| Q3 2023 | -676,079 | Reduce 60.47% | 441,987 | $22.33 |
| Q2 2023 | +1.12 M | New Buy | 1.12 M | $25.47 |
| Q1 2023 | -225,815 | Sold Out | 0 | $0.00 |
| Q4 2022 | +50,725 | Add 28.97% | 225,815 | $23.73 |
| Q3 2022 | +175,090 | New Buy | 175,090 | $16.60 |
| Q4 2021 | -184,705 | Sold Out | 0 | $0.00 |
| Q3 2021 | +184,705 | New Buy | 184,705 | $46.45 |
| Q3 2019 | -263,010 | Sold Out | 0 | $0.00 |
| Q2 2019 | -15,150 | Reduce 5.45% | 263,010 | $28.51 |
| Q1 2019 | +278,160 | New Buy | 278,160 | $25.02 |
Steven Cohen's Veracyte Investment FAQs
Steven Cohen first purchased Veracyte, Inc. (VCYT) in Q1 2019, acquiring 278,160 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Veracyte, Inc. (VCYT) for 18 quarters since Q1 2019.
Steven Cohen's largest addition to Veracyte, Inc. (VCYT) was in Q2 2023, adding 1,118,066 shares worth $28.48 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 426,229 shares of Veracyte, Inc. (VCYT), valued at approximately $17.94 M.
As of the Q4 2025 filing, Veracyte, Inc. (VCYT) represents approximately 0.02% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Veracyte, Inc. (VCYT) was 1,118,066 shares, as reported at the end of Q2 2023.